4//SEC Filing
Andrews Timothy K. 4
Accession 0001562180-18-002840
CIK 0001656328other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 9:23 PM ET
Size
8.7 KB
Accession
0001562180-18-002840
Insider Transaction Report
Form 4
Andrews Timothy K.
General Counsel & Secretary
Transactions
- Award
Stock Options (Right to buy)
2018-06-01+60,000→ 60,000 totalExercise: $15.08Exp: 2028-06-01→ Common Stock (60,000 underlying)
Holdings
- 15,000(indirect: See Footnote)
Common Stock
- 10,000(indirect: See Footnote)
Common Stock
- 53,699
Common Stock
Footnotes (4)
- [F1]Includes 1,962 shares of the Issuer's common stock acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 31, 2018.
- [F2]The shares are held directly by Steelhead Bioventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.
- [F3]The shares are held directly by the Andrews Living Trust (the "Trust"), of which the Reporting Person serves as co-trustee. The Reporting Person and members of his immediate family are beneficiaries of the Trust. The Reporting Person disclaims beneficial ownership of the shares of the Issuer's common stock held by the Trust except to the extent of his pecuniary interest therein.
- [F4]Twenty-Five percent (25%) of the shares subject to the option vest and become exercisable on the first anniversary measured from June 1, 2018, and the remaining shares subject to the option vest and become exercisable in 36 successive, equal monthly installments thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
Documents
Issuer
Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Entity typeother
Related Parties
1- filerCIK 0001711464
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 9:23 PM ET
- Size
- 8.7 KB